Allergic Rhinitis AR, an inflammatory condition produced by an IgE-mediated immunological response to inhaled allergens, is a common childhood disease. This article discusses the inducing factors, diagnosis and treatment of allergic rhinitis.

Allergic rhinitis

For individuals with allergic rhinitis (AR), primary care physicians (PCPs) are often the initial source of medical guidance. It is one of the top 10 causes of primary care clinic visits. As much as 30 per cent of adults and almost 40 per cent of youngsters will have allergic rhinitis (AR) at some point in their lives.

Nearly 80% of asthmatics have AR, while approximately 50% of AR patients have asthma. Allergic rhinitis (AR) is most prevalent in children aged 8 to 11 years.  During their formative years, adolescent rhinitis reportedly affects males more than girls and is often accompanied by nasal congestion, rhinorrhea, sneezing, and ocular symptoms (redness, tearing, and itching).

In addition, studies indicate that comorbidities such as asthma, sinusitis, and middle ear infection may develop or worsen if the initial condition is left untreated. With worldwide research indicating that the frequency of AR in preschool age groups may vary between 42.7% and the absence of a global expert agreement about its therapy, it may be required for pediatric AR to be regarded as a distinct clinical entity and addressed as such.